The Treatment Reality of Octogenarians with Bladder Cancer in a Maximum Care Hospital (2016) Sikic D, Wach S, Taubert H, Richterstetter M, Kunath F, Lieb V, Krause S, et al. Conference contribution Temozolomide resistance in human glioblastoma cell line U251 is caused by mismatch repair deficiency and can be overcome by lomustine (2016) Stritzelberger J, Distel T, Fietkau R, Putz F Conference contribution Tumor-infiltrating lymphocytes and response prediction to neoadjuvant chemotherapy in HER2-positive breast cancer (2016) Heppner BI, Untch M, Denkert C, Pfitzner BM, Lederer B, Schmidt W, Eidtmann H, et al. Conference contribution Psychooncological counseling and treatment as part of the Comprehensive Cancer Center (CCC): Multicenter study to detect the psycho-oncological needs, indications and using (2016) Buettner-Teleaga A, Weis J, Goerling U, Hornemann B, Erim Y, Beckmann M, Senf B, et al. Conference contribution Oral cavity carcinomas as primary manifestation of telomere maintenance disorders (telomeropathies) (2016) Beier F, Schmitt K, Bouillon AS, Hasenbank C, Vankann L, Ambrosch P, Hoffmann T, et al. Conference contribution Proposal for a new M1 subclassification in colorectal carcinoma (2016) Merkel S, Weber K, Croner R, Golcher H, Göhl J, Agaimy A, Semrau S, et al. Conference contribution State-of-the-Art Treatment and Novel Agents in Local and Distant Recurrences of Cervical Cancer (2016) Tempfer CB, Beckmann M Journal article What opportunities does Immuno-oncology indicate for overarching long-term survival? (2015) Bergmann L, Brugger W, Herr W, Mackensen A, Multhoff G Journal article Workshop - Ökonomische Steuerungsmechanismen: Beispiel Hämatologie und Onkologie (2015) Strech D, Deh U, Schmitz S, Guerkan I, Ostermann H, Krause S Journal article, Report Preface (2015) Hauschild A, Koelbl O, Mackensen A, Schadendorf D Journal article, Editorial